Skip to content
Screener

Price / sales at other companies

Abbott logo
AbbottABT
3.4×-2.2×
Johnson & Johnson logo
Johnson & JohnsonJNJ
6.2×+2.2×
Boston Scientific logo
Boston ScientificBSX
-5.3×
AtriCure logo
AtriCureATRC
2.5×-0.8×
Medtronic logo
MedtronicMDT
2.9×-0.4×
Merit Medical Systems logo
Merit Medical SystemsMMSI
2.7×-1.8×

Other financials

Income statement

See full
Revenue$434.0K
Gross profit$161.0K
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.65B+156%
Enterprise value$2.55B+173%

Profitability

See full
Gross margin-0.1%
Operating margin-7,007.8%
Net margin-6,755.8%
FCF margin-5,180.4%

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288

FAQ

What is Pulse Biosciences, Inc.'s price / sales?
Pulse Biosciences, Inc. (PLSE) reported price / sales of 1,619.6× in Q2 2026.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about Pulse Biosciences, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude